About GWOXI

GWOXI is deeply committed to the field of regenerative medicine, dedicating itself to the development of stem cell application technologies and the innovation of new stem cell drugs. Our mission is to address currently unmet medical needs.

By integrating its medical-grade stem cell manufacturing platform with numerous core technologies, GWOXI has accumulated hundreds of technical patents. This, combined with a strategic patent portfolio, has solidified the company's position in the cell therapy market.

Service and Quality Service and Quality Certificates To uphold the pharmaceutical-grade standards of quality control, GWOXI implements rigorous safeg

Founded in 2004, GWOXI established its presence in the Hsinchu Biomedical Science Park in 2011. The company's development journey, from new drug R&D and clinical trials to international exosome certifications, stands as a testament to the accumulation and transformation of its professional expertise in stem cell technology development.

GWOXI is centered on the development of stem cell technology. The company is planning a global strategy, enhancing its CDMO capabilities, and advancing the practical application of innovative solutions in stem cells and exosomes.

GWOXI provides diverse collaboration models, including stem cell new drug R&D, CDMO services for cell products, and technology licensing. It welcomes the industry, academia, and medical communities to jointly build the blueprint for regenerative medicine.